共 39 条
- [4] Analysis of Drug-induced Liver Injury Reported with Tumor Necrosis Factor-alpha Inhibitors to the Food and Drug Administration Adverse Event Reporting System in Inflammatory Bowel Disease [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S513 - S513
- [5] Acute heart failure as an adverse event of tumor necrosis factor inhibitor therapy in inflammatory bowel disease: A review of the literature [J]. WORLD JOURNAL OF CARDIOLOGY, 2023, 15 (05): : 217 - 228
- [7] New-Onset Inflammatory Bowel Disease During Tumor Necrosis Factor-Alpha Inhibitor Therapy for Rheumatoid Arthritis and Juvenile Rheumatoid Arthritis: A Review of the Food and Drug Administration Adverse Event Reporting System and Literature [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S621 - S622
- [8] Melanoma and non-Melanoma Skin Cancer in Inflammatory Bowel Disease Patients following Tumor Necrosis Factor-α Inhibitor Monotherapy and in Combination with Thiopurines: Analysis of the Food and Drug Administration Adverse Event Reporting System [J]. JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2014, 23 (03) : 267 - 271
- [9] Differentiating the Risk of Bacterial Infections between Individual Tumor Necrosis Factor-alpha (TNF-α) Blockers in Inflammatory Bowel Disease: A Review of the Food and Drug Administration Adverse Event Reporting System (FDA AERS) [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S649 - S650
- [10] Tumor Necrosis Factor-Alpha Blockers do not Augment the Risk of Viral Infection in Inflammatory Bowel Disease (IBD): A Review of the Food and Drug Administration Adverse Event Reporting System (FDA AERS) [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S636 - S637